Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Blinded Two-Year Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Study

被引：0

作者：

Weinblatt, Michael ^{[1
]}

Schiff, Michael ^{[2
]}

Valente, Robert ^{[3
]}

van der Heijde, Desiree ^{[4
]}

Citera, Gustavo ^{[5
]}

Elegbe, Ayanbola ^{[6
]}

Maldonado, Michael ^{[6
]}

Fleischmann, Roy ^{[7
]}

机构：

[1] Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Univ Colorado, Denver, CO 80202 USA

[3] Arthrit Ctr Nebraska, Lincoln, NE USA

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina

[6] Bristol Myers Squibb Co, Princeton, NJ USA

[7] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1476 / 1476

页数：1

共 39 条

[1] Head-To-Head Comparison Of Subcutaneous Abatacept Versus Adalimumab On Background Methotrexate In RA: Blinded Two Year Results From The Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjectswith Background Methotrexate) study
Weinblatt, Michael E.
Schiff, Michael H.
Valente, Robert
van der Heijde, Desiree M.
Citera, Gustavo
Elegbe, Ayanbola
Maldonado, Michael A.
Fleischmann, Roy M.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S991 - S992
[2] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RA: TWO YEAR RESULTS FROM THE AMPLE STUDY
Schiff, M.
Weinblatt, M.
Valente, R.
van der Heijde, D.
Citera, G.
Elegbe, A.
Maldonado, M.
Fleischmann, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 64 - 64
[3] Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Maldonado, Michael
Weinblatt, Michael
Schiff, Michael
Fleischmann, Roy
Valente, Robert
Van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1005 - 1006
[4] Head to Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Weinblatt, Michael E.
Schiff, Michael H.
Fleischmann, Roy
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
Maldonado, Michael A.
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1031 - S1031
[5] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY
Weinblatt, Michael E.
Schiff, Michael H.
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Elegbe, Ayanbola
Maldonado, Michael A.
Fleischmann, Roy
[J]. RHEUMATOLOGY, 2014, 53 : 88 - 88
[6] Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Maldonado, Michael
Fleischmann, Roy
Weinblatt, Michael
Schiff, Michael
Khanna, Dinesh
Furst, Daniel
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1006 - 1006
[7] EFFECTS OF SUBCUTANEOUS ABATACEPT OR ADALIMUMAB ON REMISSION AND ASSOCIATED CHANGES IN PHYSICAL FUNCTION AND RADIOGRAPHIC OUTCOMES: ONE YEAR RESULTS FROM THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
Fleischmann, R.
Schiff, M.
Weinblatt, M.
Maldonado, M.
Massarotti, E.
Yazici, Y.
[J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 11 - 11
[8] CHANGES IN PATIENT REPORTED OUTCOMES IN RESPONSE TO SUBCUTANEOUS ABATACEPT OR ADALIMUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
Fleischmann, R.
Weinblatt, M.
Schiff, M.
Khanna, D.
Furst, D.
Maldonado, M.
[J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 10 - 11
[9] Effects of Subcutaneous Abatacept or Adalimumab On Remission and Associated Changes in Physical Function and Radiographic Outcomes: One Year Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial.
Fleischmann, Roy
Schiff, Michael H.
Weinblatt, Michael E.
Maldonado, Michael A.
Massarotti, Elena M.
Yazici, Yusuf
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S577 - S577
[10] Changes in Patient Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic Naive RA Subjects with Background Methotrexate) Trial.
Fleischmann, Roy
Weinblatt, Michael E.
Schiff, Michael H.
Khanna, Dinesh
Furst, Daniel
Maldonado, Michael A.
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S578 - S578

← 1 2 3 4 →